Role of BM and PB Next Generation Sequencing (NGS) MRD Vs. BM Multichannel Flow Cytometry (MFC) MRD Pre/Post-Allogeneic HCT in Predicting Outcomes for Children and Young Adults (CAYA) with B-ALL: Planned Analysis of the Ptctc ONC1401 Trial | Synapse
March 3, 2026
Role of BM and PB Next Generation Sequencing (NGS) MRD Vs. BM Multichannel Flow Cytometry (MFC) MRD Pre/Post-Allogeneic HCT in Predicting Outcomes for Children and Young Adults (CAYA) with B-ALL: Planned Analysis of the Ptctc ONC1401 Trial
Puntos clave
Molecular techniques like NGS and flow cytometry provide critical insights into minimal residual disease.
The analysis focuses on comparing MRD detection pre and post-allogeneic hematopoietic cell transplantation.
Utilizing advanced methods, the study evaluates patient prognoses and their implications for future treatments.
The findings support the need for improved predictive strategies, emphasizing further validation in broader cohorts.